fleischhacker brooks (80 Ergebnisse)

4°, Original-Pappband. 141 Seiten. Illustriert. Exemplar noch originalverschweißt. Nahezu neuwertig. - in englischer Sprache. IS: 3211262911 ****An unsere Kunden in Deutschland: Versand nach Deutschland einmal in der Woche ab Freilassing mit der Deutschen Post.*** - Sprache: Englisch Gewicht in Gramm: 550.

Zustand: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Brand new book. Fast ship. Please provide full street address as we are not able to ship to P O box address.

Buch. Zustand: Neu. Neuware -The 5th Neuropsychiatry Symposium of the European Institute of Health care was devoted to neuropsychopharmacology. As in previous meetings, we sought to choose topics that bridge the gap between basic neuroscience and the clinical fields of neurology and psychiatry. Consequently, the pro ceedings published in this supplement cover a lot of ground. Late breaking data on various neuromodulator and neurotransmitter systems and their implications for the treatment of a number of disorders are reviewed. Jean Charles Schwartz and colleagues set the stage with their paper on constitu tive receptor activity, using the histamine H3-receptor to illustrate the point. The role of neuropeptides and neurotrophins in psychiatric disorders is then reviewed by Florian Holsboer, while Bill Deakin elucidates the role of sero tonin, discovered 50 years ago in the brain, in select psychiatric syndromes. New pharmacological developments in the treatment of migraine, Parkin son's disease and schizophrenia are then presented by Hans Christoph Diener, Eduardo Tolosa and Wolfgang Fleischhacker. In the end David Nutt and colleagues provide future directions in substance dependence research, linking the role of various transmitter systems with findings from neu roimaging studies. In summary, there is no doubt that progress in the field of neuropsychopharmacology is exciting and the prospects of true advances in the treatment of brain disorders are very promising.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 132 pp. Englisch.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The 5th Neuropsychiatry Symposium of the European Institute of Health care was devoted to neuropsychopharmacology. As in previous meetings, we sought to choose topics that bridge the gap between basic neuroscience and the clinical fields of neurology and psychiatry. Consequently, the pro ceedings published in this supplement cover a lot of ground. Late breaking data on various neuromodulator and neurotransmitter systems and their implications for the treatment of a number of disorders are reviewed. Jean Charles Schwartz and colleagues set the stage with their paper on constitu tive receptor activity, using the histamine H3-receptor to illustrate the point. The role of neuropeptides and neurotrophins in psychiatric disorders is then reviewed by Florian Holsboer, while Bill Deakin elucidates the role of sero tonin, discovered 50 years ago in the brain, in select psychiatric syndromes. New pharmacological developments in the treatment of migraine, Parkin son's disease and schizophrenia are then presented by Hans Christoph Diener, Eduardo Tolosa and Wolfgang Fleischhacker. In the end David Nutt and colleagues provide future directions in substance dependence research, linking the role of various transmitter systems with findings from neu roimaging studies. In summary, there is no doubt that progress in the field of neuropsychopharmacology is exciting and the prospects of true advances in the treatment of brain disorders are very promising.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The 5th Neuropsychiatry Symposium of the European Institute of Health care was devoted to neuropsychopharmacology. As in previous meetings, we sought to choose topics that bridge the gap between basic neuroscience and the clinical fields of neurology and psychiatry. Consequently, the pro ceedings published in this supplement cover a lot of ground. Late breaking data on various neuromodulator and neurotransmitter systems and their implications for the treatment of a number of disorders are reviewed. Jean Charles Schwartz and colleagues set the stage with their paper on constitu tive receptor activity, using the histamine H3-receptor to illustrate the point. The role of neuropeptides and neurotrophins in psychiatric disorders is then reviewed by Florian Holsboer, while Bill Deakin elucidates the role of sero tonin, discovered 50 years ago in the brain, in select psychiatric syndromes. New pharmacological developments in the treatment of migraine, Parkin son's disease and schizophrenia are then presented by Hans Christoph Diener, Eduardo Tolosa and Wolfgang Fleischhacker. In the end David Nutt and colleagues provide future directions in substance dependence research, linking the role of various transmitter systems with findings from neu roimaging studies. In summary, there is no doubt that progress in the field of neuropsychopharmacology is exciting and the prospects of true advances in the treatment of brain disorders are very promising.

Zustand: New. In.

Zustand: New.

Zustand: As New. Unread book in perfect condition.

Zustand: New. Editor(s): Fleischhacker, W. W.; Brooks, D.J. Series: Journal of Neural Transmission. Supplementa. Num Pages: 117 pages, 5 black & white illustrations, 4 colour illustrations, biography. BIC Classification: MMG. Category: (P) Professional & Vocational. Dimension: 280 x 216 x 6. Weight in Grams: 307. . 2003. Softcover reprint of the original 1st ed. 2003. Paperback. . . . .

Zustand: New. In.

Zustand: New. pp. 117 1st Edition.

Paperback. Zustand: Brand New. 1st edition. 117 pages. 10.80x8.30x0.20 inches. In Stock.

Zustand: New. In.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Atherosclerosis, the underlying cause of heart attacks, strokes and peripheral vascular disease, is one of the major killers in the world. By 2020 WHO statistics indicate that it will be the most common cause of morbidity and mortality in both the industrialised world and the underdeveloped world. The disease develops slowly over many years in the innermost layer of large and medium-sized arteries (Fig. 1) (Scott, 1995; Ross, 1999; Naumova and Scott, 2000; Glass and Witztum, 2001; Libby, 2001). It does not usually become manifest before the fourth of fifth decade, but then often strikes with devas tating suddenness. Fifty per cent of individuals still die (25 per cent immedi ately) from their first heart attack; and morbidity from coronary heart disease and stroke is very significant. The disease has a profound impact on health care services and on industrial economies. The lesions of atherosclerosis Autopsy studies show that in humans atherosclerosis begins in the first and second decade of life. A similar disease can be produced in experimental animals, where diet and genetics can be manipulated to produce identical lesions. The earliest lesions are fatty streaks. These consist of an accumulation of lipid-engorged macrophages (foam cells) and T and B lymphocytes in the arterial intima. With time, the fatty streaks progress to intermediate lesions, composed of foam cells and smooth muscle cells.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - We have great pleasure to present the latest extension of the European Institute of Health Care book series. This volume is devoted to neurodevelopmental d- orders. Again, we had the privilege to be able to work with reknowned experts who have agreed to contribute to this endeavour. The book comprises a number of topics related to psychosocial and motor development and is exemplary with regard to its comprehensiveness, as reviews of the topics presented are generally not available in a single publication. It starts with a timely and critical discussion of the genetics of attention deficit hyperactivity disorder by Dr. Buitelaar in which prospects and challenges of this approach are outlined. The next chapter by Drs. Nicolson and Fawcett deals with dyslexia and its relationship to cerebellar function providing a framework that can explain motor, speed, and phonological deficits in a unified approach. Diagnostic and treatment aspects of speech development disorders are the focus of Dr. Zorowka's contribution in which, among other issues, the necessity of mul- professional cooperation is stressed. Dr. Sigmundsson then focuses on disorders of motor development. 6-10 % of children have motor competence well below the norm, which often persist. The clumsy child syndrome must be seen and treated as a neurological dysfunction. The relationship between tic disorders and obsessive compulsive disorder, two disturbances generally treated by different medical specialists, namely neurologists or psychiatrists, is then reviewed by Drs.

Buch. Zustand: Neu. Neuware -Substance-related disorders pose an increasing challenge not only to the field of psychiatry but also to public health. The rapid development of our society has also changed the face of substance use and abuse, both quantitatively and qualitatively. In this volume international experts present reviews of the latest research covering many areas ranging from neurobiology to psychological management, as well as different drugs, from alcohol to ecstasy.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 132 pp. Englisch.

Buch. Zustand: Neu. Neuware -Atherosclerosis, the underlying cause of heart attacks, strokes and peripheral vascular disease, is one of the major killers in the world. By 2020 WHO statistics indicate that it will be the most common cause of morbidity and mortality in both the industrialised world and the underdeveloped world. The disease develops slowly over many years in the innermost layer of large and medium-sized arteries (Fig. 1) (Scott, 1995; Ross, 1999; Naumova and Scott, 2000; Glass and Witztum, 2001; Libby, 2001). It does not usually become manifest before the fourth of fifth decade, but then often strikes with devas tating suddenness. Fifty per cent of individuals still die (25 per cent immedi ately) from their first heart attack; and morbidity from coronary heart disease and stroke is very significant. The disease has a profound impact on health care services and on industrial economies. The lesions of atherosclerosis Autopsy studies show that in humans atherosclerosis begins in the first and second decade of life. A similar disease can be produced in experimental animals, where diet and genetics can be manipulated to produce identical lesions. The earliest lesions are fatty streaks. These consist of an accumulation of lipid-engorged macrophages (foam cells) and T and B lymphocytes in the arterial intima. With time, the fatty streaks progress to intermediate lesions, composed of foam cells and smooth muscle cells.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 164 pp. Englisch.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Substance-related disorders pose an increasing challenge not only to the field of psychiatry but also to public health. The rapid development of our society has also changed the face of substance use and abuse, both quantitatively and qualitatively. In this volume international experts present reviews of the latest research covering many areas ranging from neurobiology to psychological management, as well as different drugs, from alcohol to ecstasy.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Substance-related disorders pose an increasing challenge not only to the field of psychiatry but also to public health. The rapid development of our society has also changed the face of substance use and abuse, both quantitatively and qualitatively. In this volume international experts present reviews of the latest research covering many areas ranging from neurobiology to psychological management, as well as different drugs, from alcohol to ecstasy.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Atherosclerosis, the underlying cause of heart attacks, strokes and peripheral vascular disease, is one of the major killers in the world. By 2020 WHO statistics indicate that it will be the most common cause of morbidity and mortality in both the industrialised world and the underdeveloped world. The disease develops slowly over many years in the innermost layer of large and medium-sized arteries (Fig. 1) (Scott, 1995; Ross, 1999; Naumova and Scott, 2000; Glass and Witztum, 2001; Libby, 2001). It does not usually become manifest before the fourth of fifth decade, but then often strikes with devas tating suddenness. Fifty per cent of individuals still die (25 per cent immedi ately) from their first heart attack; and morbidity from coronary heart disease and stroke is very significant. The disease has a profound impact on health care services and on industrial economies. The lesions of atherosclerosis Autopsy studies show that in humans atherosclerosis begins in the first and second decade of life. A similar disease can be produced in experimental animals, where diet and genetics can be manipulated to produce identical lesions. The earliest lesions are fatty streaks. These consist of an accumulation of lipid-engorged macrophages (foam cells) and T and B lymphocytes in the arterial intima. With time, the fatty streaks progress to intermediate lesions, composed of foam cells and smooth muscle cells.

Zustand: New.

Paperback. Zustand: new. Paperback. The 5th Neuropsychiatry Symposium of the European Institute of Health- care was devoted to neuropsychopharmacology. As in previous meetings, we sought to choose topics that bridge the gap between basic neuroscience and the clinical fields of neurology and psychiatry. Consequently, the pro- ceedings published in this supplement cover a lot of ground. Late breaking data on various neuromodulator and neurotransmitter systems and their implications for the treatment of a number of disorders are reviewed. Jean- Charles Schwartz and colleagues set the stage with their paper on constitu- tive receptor activity, using the histamine H3-receptor to illustrate the point. The role of neuropeptides and neurotrophins in psychiatric disorders is then reviewed by Florian Holsboer, while Bill Deakin elucidates the role of sero- tonin, discovered 50 years ago in the brain, in select psychiatric syndromes. New pharmacological developments in the treatment of migraine, Parkin- son's disease and schizophrenia are then presented by Hans Christoph Diener, Eduardo Tolosa and Wolfgang Fleischhacker.In the end David Nutt and colleagues provide future directions in substance dependence research, linking the role of various transmitter systems with findings from neu- roimaging studies. In summary, there is no doubt that progress in the field of neuropsychopharmacology is exciting and the prospects of true advances in the treatment of brain disorders are very promising. The 5th Neuropsychiatry Symposium of the European Institute of HealthA care was devoted to neuropsychopharmacology. As in previous meetings, we sought to choose topics that bridge the gap between basic neuroscience and the clinical fields of neurology and psychiatry. Consequently, the proA ceedings published in this supplement cover a lot of ground. Late breaking data on various neuromodulator and neurotransmitter systems and their implications for the treatment of a number of disorders are reviewed. JeanA Charles Schwartz and colleagues set the stage with their paper on constituA tive receptor activity, using the histamine H3-receptor to illustrate the point. The role of neuropeptides and neurotrophins in psychiatric disorders is then reviewed by Florian Holsboer, while Bill Deakin elucidates the role of seroA tonin, discovered 50 years ago in the brain, in select psychiatric syndromes. New pharmacological developments in the treatment of migraine, ParkinA son's disease and schizophrenia are then presented by Hans Christoph Diener, Eduardo Tolosa and Wolfgang Fleischhacker. In the end David Nutt and colleagues provide future directions in substance dependence research, linking the role of various transmitter systems with findings from neuA roimaging studies. In summary, there is no doubt that progress in the field of neuropsychopharmacology is exciting and the prospects of true advances in the treatment of brain disorders are very pro Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

Zustand: New. In.

Zustand: New.

Zustand: New.

Zustand: New.

Gebunden. Zustand: New. We have great pleasure to present the latest extension of the European Institute of Health Care book series. This volume is devoted to neurodevelopmental d- orders. Again, we had the privilege to be able to work with reknowned experts who have agreed to con.

Zustand: New. Editor(s): Fleischhacker, W. W.; Brooks, D.J. Series: Journal of Neural Transmission. Supplementa. Num Pages: 117 pages, 5 black & white illustrations, 4 colour illustrations, biography. BIC Classification: MMG. Category: (P) Professional & Vocational. Dimension: 280 x 216 x 6. Weight in Grams: 307. . 2003. Softcover reprint of the original 1st ed. 2003. Paperback. . . . . Books ship from the US and Ireland.